I-SPY 2 low risk registry: An I-SPY 2 trial sub-study for women with clinically advanced, ER+, HER2- breast cancer and molecular good-prognosis gene signature. Background: A potential mechanism of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback